Nilotinib Hydrochloride Monohydrate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AMN 107, AMN-107, AMN107, Nilotinib Monohydrochloride Monohydrate, Tasigna

Filter by location:

Birmingham, Alabama1 trial

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

University of Alabama at Birmingham Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.